August 6, 2025

Una discusión sobre los medicamentos para el síndrome del cromosoma X frágil, con la Dra. Randi J. Hagerman, profesora distinguida de Pediatría, presidenta de investigación del síndrome del cromosoma X frágil e investigadora del Instituto MIND de UC Davis.

July 17, 2025

In this keynote session at the 19th NFXF International Fragile X Conference, Dr. Peter Todd discusses the history, challenges, and advancements that have helped shape the trajectory of treatments for Fragile X-associated conditions.

June 8, 2020

We asked Dr. Craig Erickson, the director of the Cincinnati Fragile X Research and Treatment Center, to answer the question, Can I use CBD to treat Fragile X syndrome? Watch as he discusses the use of cannabidiol (CBD) for people with FXS.

February 21, 2024

During this 45-minute Lunch & Learn webinar, Dr. Erickson discussed details of a single-dose medication study in Fragile X syndrome (FXS), including how the study was done, what the results showed, and moreover, why the results are important, what they mean for the FXS community, and next steps to move us forward.

January 30, 2024
07 mins read

Research Summary: The results found from the EEGs in both the FMR1 KO mice and humans with FXS are extremely important for the future of FXS research because they show a measurable commonality between the two very different species.

June 8, 2023
06 mins read

Allos Pharma announced they held a meeting with the FDA to optimize the design of their Phase 3 trial designed to support an NDA to address FXS.

October 28, 2022
07 mins read

Healx shares the closing of their IMPACT-FXS trial with plans to open a new study in early 2023.

July 17, 2022

This panel discussion is on the topic of medications and treatments available for Fragile X Syndrome.

July 17, 2022

This session will cover currently available supportive medications for treating anxiety, irritability, and agitated and aggressive behaviors that can be problematic in Fragile X syndrome. Medication classes and specific medications within each class will be described.

July 15, 2022

This session is designed for those considering starting medications for their child and/or those who would like new strategies and approaches to considering medication changes.

March 13, 2022

Jayne Dixon Weber and Dr. Craig Erickson discuss new medications and review existing medications used for various issues related to Fragile X syndrome.

April 29, 2021
10 mins read

Dr. Liz Berry-Kravis and Tetra Therapeutics published the BPN14770 trial results in Nature Medicine on April 29, 2021. We present a summary of those research results.

November 19, 2020
02 mins read

Allos Pharma, a late-stage pharmaceutical company developing therapeutics for neurodevelopmental disorders, has announced the exclusive license rights to arbaclofen in Fragile X syndrome.

July 13, 2020

Our distinguished presenters discuss currently available supportive medications for treating anxiety and irritable, agitated, and aggressive behaviors in Fragile X syndrome.

May 30, 2020

Our expert panel discusses and takes questions about medications.